Invention Grant
- Patent Title: Pteridines as FGFR inhibitors
- Patent Title (中): Pteridines作为FGFR抑制剂
-
Application No.: US14404175Application Date: 2013-05-30
-
Publication No.: US09447098B2Publication Date: 2016-09-20
- Inventor: Gordon Saxty , Christopher Charles Frederick Hamlett , Valerio Berdini , Christopher William Murray , Patrick René Angibaud , Olivier Alexis Georges Querolle , Virginie Sophie Poncelet
- Applicant: ASTEX THERAPEUTICS LIMITED
- Applicant Address: GB Cambridge
- Assignee: ASTEX THERAPEUTICS LTD
- Current Assignee: ASTEX THERAPEUTICS LTD
- Current Assignee Address: GB Cambridge
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Priority: GB1209613.7 20120530
- International Application: PCT/GB2013/051427 WO 20130530
- International Announcement: WO2013/179033 WO 20131205
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; A61K31/519 ; C07D475/00 ; A61K45/06
Abstract:
The invention relates to new pteridine derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer
Public/Granted literature
- US20150291589A1 PTERIDINES AS FGFR INHIBITORS Public/Granted day:2015-10-15
Information query
IPC分类:
